Groundbreaking Advances in Stem Cell Therapy for Type 1 Diabetes
In a landmark development for stem cell research and diabetes treatment, Vertex Pharmaceuticals has achieved remarkable success with their investigational therapy VX-880 for type 1 diabetes (T1D). This breakthrough, based on longstanding research from Harvard Stem Cell Institute’s Melton Lab, represents one of the first practical applications of embryonic stem cells in treating a major […]
Read More »